TORONTO--(BUSINESS WIRE)--Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to announce that it has met the regulatory requirements and has achieved approval from the Brazil Health Authority (ANVISA) to import its first formulated CBD product into Brazil. Heritage has also achieved stability on two additional products that are awaiting final approval.
In 2021, Health Canada granted Heritage with the first ever license to export cannabis products from Canada to Brazil, and Heritage successfully shipped products to enter the testing phase with ANVISA.
“This is a very important step for Heritage as we continue to expand the reach of our high quality products beyond the borders of Canada,” said David Schwede, CEO of Heritage. “Brazil has a very healthy market outlook due to its large population, and we are poised and in position to leverage our early entry in the market and take advantage of the many opportunities in the CBD product space.”
About Heritage Cannabis Holdings Corp.
Heritage Cannabis is a leading cannabis company offering innovative products to both the medical and recreational legal cannabis markets in Canada and the U.S., operating under two licensed manufacturing facilities in Canada. The company has an extensive portfolio of high-quality cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, Thrifty, feelgood., the CB4 suite of medical products in Canada and ArthroCBD in the U.S.
ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.
“David Schwede”
David Schwede, CEO
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release.
